Journal of Histochemistry & Cytochemistry · 2005 · 11 citations · 12 references
MedicineGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsPrenatal DiagnosisInvasive Prenatal TestingNoninvasive Prenatal TestingPregnancyPregnancy DiagnosisPrenatal Genetic DiagnosisPrenatal Molecular TestingCell-free Fetal Dna TestingNon-invasive Prenatal TestingPrenatal Diagnosis Of Chromosomal DisordersPrenatal Molecular DiagnosisPrenatal Sex DeterminationSry Gene AbnormalitiesY Chromosome DetectionY-linked Disorders
Sixty blood samples from pregnant women during gestational weeks 9-28 were investigated. Cell-free fetal DNA was extracted from maternal plasma or serum to be detected by nested PCR for determination of fetal gender. The SRY gene as a marker for fetal Y chromosome was detected in 34/36 women carrying a male fetus. In 3/24 women carrying female fetuses, the SRY sequence was also detected. Overall, fetal sex was correctly predicted in 91.7% of the cases. Therefore, the new, non-invasive method of prenatal diagnosis of fetal gender for women at risk of producing children with X-linked disorders is reliable, secure, and can substantially reduce invasive prenatal tests.
12
Presence of fetal DNA in maternal plasma and serum
Yuk Ming Dennis Lo, Noemi Corbetta, P. Chamberlain et al. · The Lancet · 1997 · 3.1K citations
Quantitative Abnormalities of Fetal DNA in Maternal Serum in Preeclampsia
Yuk Ming Dennis Lo, Tse Ngong Leung, Mark Tein et al. · Clinical Chemistry · 1999 · 481 citations · Full text